Evidence map›Paper›PMID 30587596›Full record

ReviewIn vivo (Athens, Greece)

Lack of Awareness of Dietary Sources of Phosphorus Is a Clinical Concern.

Michiko Shimada, Yoshiko Shutto-Uchita, Hideaki Yamabe

Abstract readReview
In one paragraph

Review in In vivo (Athens, Greece). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Trial
  2. A Pilot Clinical Trial of a Nutrition Education Program on Quality of Life in CKD.Clinical journal of the American Society of Nephrology : CJASN · 2025
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Michiko ShimadaDepartment of Cardiology and Nephrology, Hirosaki University Graduate School of Medicine, Hirosaki, Japan.
Yoshiko Shutto-UchitaTsuchiura Kyodo Hospital Namegata District Medical Center, Namegata, Japan.
Hideaki YamabeEST clinic, Hirosaki, Japan h-yamabe@lapis.plala.or.jp.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Hyperphosphatemia is a serious complication in patients with chronic kidney disease (CKD), and is associated with more rapid progression as well as higher risk of mortality, and higher rate of cardiovascular disease accidents. CKD patients are usually advised to adopt a low phosphate diet in addition to phosphate-lowering medications, if necessary. However, there is a lack of awareness of the dietary sources of phosphate, especially hidden phosphate intake from phosphate additives in processed foods and carbonated beverages. Appropriate nutritional education could be an effective solution in reducing phosphate toxicity without introducing an additional pill burden or malnutrition.

Indexed as

Cardiovascular DiseasesFibroblast Growth Factor-23HumansHyperphosphatemiaMalnutritionPhosphorus, DietaryRenal Insufficiency, ChronicRisk FactorsFGF23 protein, humanFibroblast Growth Factor-23Phosphorus, DietaryCKDFGF-23food additiveshemodialysisKlothoPhosphorusreview

Identifiers

PMID30587596
PMCPMC6364062

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.